TRIM2 and viral infectious disease: TRIM-2 knockdown experiments using JUNV or pseudo-typed retroviruses bearing JUNV’s GP on their surface revealed that TRIM-2 restricts viral infection at the entry stage, more specifically, at a post-binding step [81].